16
Participants
Start Date
March 31, 2010
Primary Completion Date
October 31, 2011
Study Completion Date
October 31, 2011
combination therapy using decitabine and midostaurin
"Cohort 1:~Decitabine 20mg/m2 IV daily on days 1-5 to be repeated every 28 days. Midostaurin 25mg bid days 8-21 of each cycle.~Cohort 2:~Decitabine 20mg/m2 IV daily on days 1-5 to be repeated every 28 days. Midostaurin 50mg bid days 8-21 of each cycle.~Cohort 3:~Decitabine 20mg/m2 IV daily on days 1-5 to be repeated every 28 days. Midostaurin 50mg bid x 28 days of each cycle."
University of Kansas Medical Center, Westwood Campus, Kansas City
Collaborators (1)
Novartis
INDUSTRY
University of Kansas
OTHER